Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer

Decera Clinical Education Oncology Podcast · Mar 17, 2021 · 7m

In this episode, D. Ross Camidge, MD, PhD, and Joel W. Neal, MD, PhD, answer questions on investigational antibody-drug conjugates for advanced NSCLC

Presenters:

Ross Camidge, MD, PhD

Professor of Medicine/Oncology

University of Colorado Cancer Center

Aurora, Colorado

Joel W. Neal, MD, PhD

Associate Professor of Medicine

Division of Oncology

Department of Medicine

Stanford University

Attending Physician

Stanford Cancer Institute

Palo Alto, California

Content based on an online IME program supported by educational grants from Daiichi Sankyo, Inc .

Link to full program:

http://bit.ly/3twpIyl…